These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34233260)

  • 1. Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss.
    Xiong S; Zhu D; Liang B; Li M; Pan W; He J; Wang H; Sutter K; Dittmer U; Lu M; Liu D; Yang D; Liu J; Zheng X
    EBioMedicine; 2021 Jul; 69():103464. PubMed ID: 34233260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment.
    Li X; Xu L; Lu L; Liu X; Yang Y; Wu Y; Zhu T; Li X; Li Y; Song X; Han Y; Lyu W; Cao W; Li T
    J Transl Med; 2024 Oct; 22(1):901. PubMed ID: 39367456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
    Loggi E; Bihl FK; Cursaro C; Granieri C; Galli S; Brodosi L; Furlini G; Bernardi M; Brander C; Andreone P
    PLoS One; 2013; 8(6):e65327. PubMed ID: 23750252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients.
    Kim JH; Ghosh A; Ayithan N; Romani S; Khanam A; Park JJ; Rijnbrand R; Tang L; Sofia MJ; Kottilil S; Moore CB; Poonia B
    Sci Rep; 2020 Feb; 10(1):1835. PubMed ID: 32020034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
    Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
    J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
    Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
    Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative determination of HBsAg in blood sera and hepatitis B virus covalently closed circular DNA in liver tissue as markers of chronic viral hepatitis B activity].
    Semenov AV; Vlasova IA; Ostankova IuV; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):55-61. PubMed ID: 24738295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
    Vyas AK; Sharma BC; Sarin SK; Trehanpati N
    Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV.
    Vanwolleghem T; Groothuismink ZMA; Kreefft K; Hung M; Novikov N; Boonstra A
    J Hepatol; 2020 Jul; 73(1):52-61. PubMed ID: 32061650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
    Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
    Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.
    Gane E; Lim YS; Kim JB; Jadhav V; Shen L; Bakardjiev AI; Huang SA; Cathcart AL; Lempp FA; Janas MM; Cloutier DJ; Kaittanis C; Sepp-Lorenzino L; Hinkle G; Taubel J; Haslett P; Milstein S; Anglero-Rodriguez YI; Hebner CM; Pang PS; Yuen MF
    J Hepatol; 2023 Oct; 79(4):924-932. PubMed ID: 37290591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and clinical management of HIV-HBV coinfected patients in a large AIDS Reference Center in Belgium.
    Farid Y; Martin C; Delforge M; De Wit S
    Acta Clin Belg; 2019 Dec; 74(6):424-429. PubMed ID: 30513065
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation.
    Islam M; Sevak JK; Sharma MK; Jindal A; Vyas AK; Bajpai M; Ramakrishna G; Sarin SK; Trehanpati N
    Aliment Pharmacol Ther; 2023 Mar; 57(6):689-708. PubMed ID: 36411952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.
    Loirat D; Mancini-Bourgine M; Abastado JP; Michel ML
    Int Immunol; 2003 Oct; 15(10):1125-36. PubMed ID: 13679383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection.
    Aliabadi E; Urbanek-Quaing M; Maasoumy B; Bremer B; Grasshoff M; Li Y; Niehaus CE; Wedemeyer H; Kraft ARM; Cornberg M
    Gut; 2022 Nov; 71(11):2300-2312. PubMed ID: 34702717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
    J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    Bruder Costa J; Dufeu-Duchesne T; Leroy V; Bertucci I; Bouvier-Alias M; Pouget N; Brevot-Lutton O; Bourliere M; Zoulim F; Plumas J; Aspord C;
    PLoS One; 2016; 11(6):e0158297. PubMed ID: 27348813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.